CanVECTOR in the News

Latest CanVECTOR News
« Back to listings

CanVECTOR COVID-19 VTE-Related Rapid Response Funding Competition Results Announced


MONTREAL, September 16, 2020 – In July 2020 CanVECTOR launched a special call for proposals to support research projects to enable network scientists to collect data to improve the understanding of COVID-19 in relation to venous thromboembolism (VTE) risk, diagnosis, prevention, management, and pathogenesis. The competition was launched in response to the urgent need to better understand the pathobiology and clinical implications of the viral infection that leads to the thrombosis-related morbidity and mortality seen with COVID-19.

The network received eight applications which were reviewed by a competition committee consisting of nine scientific reviewers and two patient partner reviewers. In a highly competitive review process, the competition committee awarded two grants of $50,000 (CAD) each to help conduct the studies over a one-year period.

“We’re very proud of the network’s ability to respond in such a timely manner to the urgent need to better understand the pathobiology and clinical implications of COVID-19 as it relates to thrombosis-related morbidity…We received strong applications from researchers from across the county - both clinical and basic science, and in a highly competitive review process were able to fund two important, feasible, and promising research studies to help answer pivitol research questions.”  - Dr. Susan Kahn, Co-Director, CanVECTOR Network

The following studies were awarded research grants:

  • Project 1: The role of complement in SARS-CoV-2-triggered thrombosis
    • Principal Applicant: Dr. Edward Conway, MD, PhD (University of British Columbia)
    • Research Team: Dr. Alex Leatherdale, PhD; Kevin Gonzalez, MSc / PhD Student
    • Institution: University of British Columbia, Vancouver, Canada.
  • Project 2: Anticoagulation in hospitalized patients with COVID-19: an individual patient data network meta-analysis
    • Principal Applicant: Dr. Tobias Tritschler, MD (University of Bern) and Dr. Grégoire Le Gal, MD, PhD (University of Ottawa).
    • Institution: Ottawa Hospital Research Institute, Ottawa, Canada.

Media Contact

For more information about the COVID-19 VTE-Related Rapid Response Funding competition, please contact Jessie Micholuk, CanVECTOR Network Manager, by email:


There are currently no comments.

Log in to post a comment.